| C07AB02 |
Metoprolol |
METOPROLOL STADA |
Tablet |
50 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
3.01 |
- |
0.1895 |
1.9 |
100% |
1.9 |
|
I10 |
HCP-8740/13.04.2016 |
02.08.2019 |
08.09.2012 |
|
Активен |
12 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA |
Tablet |
100 |
mg |
20 |
Stada Arzneimittel AG, Германия |
150 |
mg |
3.01 |
- |
0.1895 |
2.53 |
100% |
2.53 |
|
I10 |
HCP-8740/13.04.2016 |
02.08.2019 |
08.09.2012 |
|
Активен |
13 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA |
Tablet |
50 |
mg |
20 |
Stada Arzneimittel AG, Германия |
150 |
mg |
2.23 |
- |
0.1895 |
1.26 |
100% |
1.26 |
|
I10 |
HCP-8740/13.04.2016 |
02.08.2019 |
08.09.2012 |
|
Активен |
11 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA 200 RETARD |
Prolonged release tablet |
200 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
9.54 |
- |
0.1895 |
7.58 |
100% |
7.58 |
|
I10 |
HCP-8740/13.04.2016 |
02.08.2019 |
08.09.2012 |
|
Активен |
16 |
| C07AB02 |
Metoprolol |
METOPROLOL STADA 200 RETARD |
Prolonged release tablet |
200 |
mg |
20 |
Stada Arzneimittel AG, Германия |
150 |
mg |
6.91 |
- |
0.1895 |
5.05 |
100% |
5.05 |
|
I10 |
HCP-8740/13.04.2016 |
02.08.2019 |
08.09.2012 |
|
Активен |
15 |
| C07AB02 |
Metoprolol |
Metoprol tartrate Accord |
Tablet |
100 |
mg |
30 |
Accord Healthcare Polska Sp. z.o.o., Полша |
150 |
mg |
3.91 |
- |
0.1895 |
3.79 |
100% |
3.79 |
|
I10 |
HCP-8746/13.04.2016; НСР-21768/25.06.2020 |
02.08.2020 |
08.09.2012 |
|
Активен |
1105 |
| C07AB02 |
Metoprolol |
Metoprol tartrate Accord |
Tablet |
50 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
150 |
mg |
3.79 |
- |
0.1895 |
1.9 |
100% |
1.9 |
|
I10 |
HCP-8746/13.04.2016.; НСР-16814/20.09.2018; НСР-19299/18.07.2019 |
02.09.2019 |
08.09.2012 |
|
Заличен |
1104 |
| C07AB02 |
Metoprolol |
Metostad CR |
Prolonged release tablet |
95 mg |
(съответстващ на 100mg metoprolol tartrate) |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
10.32 |
- |
0.1895 |
3.79 |
100% |
3.79 |
|
I10 |
НСР-14437/10.11.2017 |
02.08.2019 |
|
|
Активен |
15717 |
| C07AB02 |
Metoprolol |
Metostad CR |
Prolonged release tablet |
47.5 mg |
(съответстващ на 50mg metoprolol tartrate) |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
8.17 |
- |
0.1895 |
1.9 |
100% |
1.9 |
|
I10 |
НСР-14437/10.11.2017 |
02.08.2019 |
|
|
Активен |
15714 |
| C07AB02 |
Metoprolol |
Succiprol |
Prolonged release tablet |
47.5 mg (съответстващ на 50 mg metoprolol tartrate) |
|
60 |
Teva B.V., Нидерландия |
150 |
mg |
8.88 |
- |
0.1895 |
3.79 |
100% |
3.79 |
|
I10 |
HCP-8748/13.04.2016; НСР-17084/26.10.2018; НСР-17441/06.12.2018 |
02.08.2019 |
|
|
Активен |
3169 |
| C07AB02 |
Metoprolol |
Succiprol |
Prolonged release tablet |
95 mg (съответстващ на 100 mg metoprolol tartrate) |
|
60 |
Teva B.V., Нидерландия |
150 |
mg |
13.16 |
- |
0.1895 |
7.58 |
100% |
7.58 |
|
I10 |
HCP-8748/13.04.2016; НСР-17084/26.10.2018; НСР-17325/22.11.2018 |
02.08.2019 |
|
|
Активен |
3168 |
| C07AB03 |
Atenolol |
C07AB03 Atenolol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C07AB03 |
Atenolol |
ATENOLOL ACTAVIS |
Film coated tablet |
50 |
mg |
30 |
Актавис EАД, България |
75 |
mg |
- |
2.44 |
0.122 |
2.44 |
50% |
1.22 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-16042/29.06.2018 |
02.08.2018 |
08.09.2012 |
|
Заличен |
242 |
| C07AB03 |
Atenolol |
ATENOLOL ACTAVIS |
Film coated tablet |
25 |
mg |
30 |
Актавис EАД, България |
75 |
mg |
- |
1.75 |
0.122 |
1.22 |
50% |
0.61 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-6394/03.06.2015.; НСР-15465/19.04.2018 |
02.06.2018 |
08.09.2012 |
|
Заличен |
241 |
| C07AB03 |
Atenolol |
ATENOLOL ACTAVIS |
Film coated tablet |
25 |
mg |
30 |
Актавис EАД, България |
75 |
mg |
- |
1.75 |
0.122 |
1.22 |
50% |
0.61 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-6393/03.06.2015 |
02.07.2015 |
08.09.2012 |
|
Заличен |
241 |
| C07AB03 |
Atenolol |
ATENOLOL SOPHARMA |
Film coated tablet |
50 |
mg |
30 |
Софарма АД, България |
75 |
mg |
- |
2.38 |
0.119 |
2.38 |
50% |
1.19 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-20818/13.02.2020 |
02.03.2020 |
08.09.2012 |
|
Активен |
173 |
| C07AB03 |
Atenolol |
ATENOLOL SOPHARMA |
Film coated tablet |
25 |
mg |
30 |
Софарма АД, България |
75 |
mg |
- |
1.28 |
0.119 |
1.19 |
50% |
0.59 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
|
02.03.2020 |
08.09.2012 |
|
Активен |
174 |
| C07AB03 |
Atenolol |
ATENOLOL-TCHAIKAPHARMA |
Tablet |
50 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
- |
2.44 |
0.122 |
2.44 |
50% |
1.22 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-12085/21.03.2017 |
02.05.2017 |
08.09.2012 |
|
Заличен |
566 |
| C07AB03 |
Atenolol 100% |
C07AB03 Atenolol 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C07AB03 |
Atenolol |
ATENOLOL SOPHARMA |
Film coated tablet |
50 |
mg |
30 |
Софарма АД, България |
75 |
mg |
2 |
- |
0.1 |
2 |
100% |
2 |
|
I10 |
HCP-8750/13.04.2016; НСР-20818/13.02.2020 |
02.03.2020 |
08.09.2012 |
|
Активен |
173 |
| C07AB03 |
Atenolol |
ATENOLOL SOPHARMA |
Film coated tablet |
25 |
mg |
30 |
Софарма АД, България |
75 |
mg |
1.08 |
- |
0.1 |
1 |
100% |
1 |
|
I10 |
HCP-8750/13.04.2016 |
02.03.2020 |
08.09.2012 |
|
Активен |
174 |
| C07AB07 |
Bisoprolol hemifumarate |
C07AB07 Bisoprolol hemifumarate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C07AB07 |
Bisoprolol |
Bibloc |
Film coated tablet |
10 |
mg |
30 |
Sandoz d.d., Словения |
10 |
mg |
- |
4.36 |
0.082 |
2.46 |
50% |
1.23 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
КЦРР-1726/04.12.2012.; HCP-8619/31.03.2016.; НСР-15155/02.03.2018; НСР-18065/01.03.2019 |
02.04.2019 |
|
|
Заличен |
1473 |
| C07AB07 |
Bisoprolol |
Bibloc |
Film coated tablet |
5 |
mg |
30 |
Sandoz d.d., Словения |
10 |
mg |
- |
2.27 |
0.082 |
1.23 |
50% |
0.62 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
КЦРР-1726/04.12.2012 г.; НСР-5515/29.01.2015; КП-236/11.05.2015 и НСР-2766/17.02.2014.; HCP-8619/31.03.2016.; КЦРР-1726/04.12.2012 г.; НСР-5515/29.01.2015; КП-236/11.05.2015 и НСР-2766/17.02.2014.; HCP-8619/31.03.2016; Решение на ВАС № 8280/05.07.2016; ВАС № 8280/05.07.2016 и НСР-5515/29.01.2015; НСР-15154/02.03.2018; НСР-18066/01.03.2019 |
02.04.2019 |
|
|
Заличен |
3905 |
| C07AB07 |
Bisoprolol |
Biprol |
Film coated tablet |
5 |
mg |
30 |
Нео Балканика ЕООД, България |
10 |
mg |
- |
5.54 |
0.082 |
1.23 |
50% |
0.61 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
НСР-20935/05.03.2020, НСР -21081/30.03.2020 предварително изпълнение |
02.04.2020 |
|
|
Активен |
2609 |